☆ 4.6 Article

A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenoma

NEURO-ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, Research & Experimental

ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer

Rui Sun et al.

Summary: The study found that the m6A modification was reduced in ovarian cancers with LN metastases. Overexpression of ALKBH5 increased tumor-associated lymphangiogenesis and LN metastasis. Blocking ITGB1 and FAK kinase-inhibitors shows promise as anti-metastatic agents.

THERANOSTICS (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting integrin pathways: mechanisms and advances in therapy

Xiaocong Pang et al.

Summary: Integrins are cell-adhesion receptors that play important roles in cell signaling and communication. Targeting integrins for therapeutic purposes has been challenging due to their complexity and opposing characteristics. Currently, there are only seven approved drugs targeting integrins on the market, but there are ongoing efforts to develop new therapies and diagnostic tools. Understanding the regulatory mechanisms of integrins and addressing unmet clinical needs are crucial for successful development of integrin-targeted therapies.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Add to Collection

Article Cell Biology

Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression

Jieqi Zhou et al.

Summary: ADAM15 promotes cell proliferation and metastasis in NSCLC by regulating the interaction between integrins and the EGFR/FAK signaling pathway, and it may serve as a potential target for NSCLC treatment.

CELL DEATH & DISEASE (2022)

Add to Collection

Article Medicine, General & Internal

Classifying Pituitary Adenoma Invasiveness Based on Radiological, Surgical and Histological Features: A Retrospective Assessment of 903 Cases

Liang Lu et al.

Summary: Invasiveness is an important predictor of surgical outcome and long-term prognosis in patients with pituitary adenomas (PAs). This study assessed PA invasiveness through radiological, surgical, and histological perspectives and established a classification scheme to predict invasive behavior and poor prognosis. The study found that radiological and surgical invasiveness were better predictors of complete resection and recurrence/progression-free survival rates than histological invasiveness. Knosp grades with surgical invasiveness were also better predictors of prognosis compared to Knosp grades without surgical invasiveness. The classification schemes developed based on invasiveness and Knosp classification were found to be clinically valuable in predicting prognosis.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Oncology

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019

Quinn T. Ostrom et al.

Summary: The report provides the latest data on primary brain tumors in the United States, including incidence rates, mortality rates, and relative survival rates. The overall incidence rate is higher in females and non-Hispanic population, and glioblastoma is the most common malignant brain tumor, while meningioma is the most common non-malignant brain tumor. The relative survival rate is lower for malignant brain tumors and higher for non-malignant brain tumors.

NEURO-ONCOLOGY (2022)

Add to Collection

Article Oncology

The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma

Xiaojin Liu et al.

Summary: This study revealed a malignant positive feedback loop between tumor-associated macrophages (TAMs) and GBM cells mediated by ADAM8 under TMZ treatment. This loop involves the activation of the HB-EGF/EGFR signaling pathway and up-regulation of CCL2 expression, leading to TAM recruitment and further enhancing ADAM8 expression in GBM cells, resulting in TMZ resistance in GBM.

CANCERS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

A novel methylated cation channel TRPM4 inhibited colorectal cancer metastasis through Ca2+/Calpain-mediated proteolysis of FAK and suppression of PI3K/Akt/mTOR signaling pathway

Chan Wang et al.

Summary: The study found that TRPM4 is a novel methylated tumor suppressor gene that is downregulated in colorectal cancer. TRPM4 activates calpain-mediated cleavage of FAK through modulating the PI3K/Akt/mTOR signaling cascade, thereby impeding CRC migration and invasion.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

Add to Collection

Article Pharmacology & Pharmacy

Convection-Enhanced Delivery of a First-in-Class Anti-β1 Integrin Antibody for the Treatment of High-Grade Glioma Utilizing Real-Time Imaging

Chibueze D. Nwagwu et al.

Summary: The study design of a Phase I clinical trial for OS2966 leverages multiple innovations including the latest CED technology, a 2-part design, a first-in-class investigational therapeutic, and concentration-based dosing.

PHARMACEUTICS (2021)

Add to Collection

Article Cell Biology

Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression

Yue Wang et al.

Summary: ALDH3B2 promotes tumor proliferation and metastasis in CCA by regulating the expression of ITGB1 and upregulating its downstream signaling pathway. The double-positive expression of ITGB1 and ALDH3B2 serves as a better prognostic biomarker of CCA.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Cell Biology

14-3-3 proteins stabilize LGI1-ADAM22 levels to seizure thresholds in mice

Norihiko Yokoi et al.

Summary: The percentage of protein function required to prevent disease symptoms is a crucial question in genetic disorders. This study found that dual phosphorylation of ADAM22 by PKA regulates high-affinity binding of ADAM22 to dimerized 14-3-3, protecting LGI1-ADAM22 from degradation. Results suggest that targeting PKA or 14-3-3 could increase LGI1-ADAM22 complexes beyond necessary levels for epilepsy treatment.

CELL REPORTS (2021)

Add to Collection

Review Endocrinology & Metabolism

Aggressive pituitary tumours and pituitary carcinomas

Gerald Raverot et al.

Summary: Anterior pituitary tumors are usually benign but can exhibit aggressive behavior, potentially developing into pituitary carcinomas. Current treatment approaches primarily involve surgery or radiotherapy, with standard medical treatments often ineffective and the need for personalized use of emerging therapies for better outcomes.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Role of c-Met/β1 integrin complex in the metastatic cascade in breast cancer

Darryl Lau et al.

Summary: The study found that the c-Met/beta 1 complex plays a crucial role in promoting intravasation and vessel wall adhesion of triple-negative breast cancer cells, potentially increasing mesenchymal and stem cell characteristics. Therapeutic approaches targeting this complex can reduce invasion and metastasis of breast cancer cells, as well as decrease the risk of bone metastases.

JCI INSIGHT (2021)

Add to Collection

Review Endocrinology & Metabolism

Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms

Vinaya Srirangam Nadhamuni et al.

ENDOCRINE REVIEWS (2020)

Add to Collection

Article Medicine, General & Internal

ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis

Sara Charmsaz et al.

BMC MEDICINE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

A disintegrin and metalloprotease 22 accelerates neointima formation by activating ERK signaling

Shu-Min Zhang et al.

ATHEROSCLEROSIS (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Functions of A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous system

Hung-En Hsia et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Add to Collection

Article Medicine, Research & Experimental

ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway

Junwen Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Add to Collection

Article Oncology

CD31 regulates metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway

Yuan-Yuan Zhang et al.

CANCER LETTERS (2018)

Add to Collection

Review Biochemistry & Molecular Biology

The pleiotropic roles of ADAM9 in the biology of solid tumors

Victor O. Oria et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Add to Collection

Article Oncology

ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma

Yong Li et al.

EXPERIMENTAL CELL RESEARCH (2018)

Add to Collection

Article Medicine, Research & Experimental

Increase in Ca2+ current by sustained cAMP levels enhances proliferation rate in GH3 cells

Andreia Laura Rodrigues et al.

LIFE SCIENCES (2018)

Add to Collection

Article Multidisciplinary Sciences

Structural basis of epilepsy-related ligand-receptor complex LGI1-ADAM22

Atsushi Yamagata et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Article Cell Biology

Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the α(v)β(3) integrin receptor

D. M. Elizondo et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2016)

Add to Collection

Review Pharmacology & Pharmacy

Integrins in glioblastoma: Still an attractive target?

Mayra Paolillo et al.

PHARMACOLOGICAL RESEARCH (2016)

Add to Collection

Article Oncology

Whole-exome sequencing identifies variants in invasive pituitary adenomas

Xiaolei Lan et al.

ONCOLOGY LETTERS (2016)

Add to Collection

Review Food Science & Technology

A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions

Nives Giebeler et al.

TOXINS (2016)

Add to Collection

Article Oncology

The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells

Fangyong Dong et al.

NEURO-ONCOLOGY (2015)

Add to Collection

Article Medical Laboratory Technology

CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers

Ivana Fridrichova et al.

TRANSLATIONAL RESEARCH (2015)

Add to Collection

Article Multidisciplinary Sciences

ADAM8 as a drug target in pancreatic cancer

Uwe Schlomann et al.

NATURE COMMUNICATIONS (2015)

Add to Collection

Article Gastroenterology & Hepatology

FAK Is Required for c-Met/beta-Catenin-Driven Hepatocarcinogenesis

Na Shang et al.

HEPATOLOGY (2015)

Add to Collection

Review Oncology

β1 Integrin: Critical Path to Antiangiogenic Therapy Resistance and Beyond

Arman Jahangiri et al.

CANCER RESEARCH (2014)

Add to Collection

Article Oncology

Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models

Lei Cao et al.

JOURNAL OF NEURO-ONCOLOGY (2014)

Add to Collection

Article Clinical Neurology

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up

Jacqueline Trouillas et al.

ACTA NEUROPATHOLOGICA (2013)

Add to Collection

Article Oncology

Global Characterization of the SRC-1 Transcriptome Identifies ADAM22 as an ER-Independent Mediator of Endocrine-Resistant Breast Cancer

Damian McCartan et al.

CANCER RESEARCH (2012)

Add to Collection

Article Biochemistry & Molecular Biology

LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11

Koji Sagane et al.

International Journal of Biological Sciences (2012)

Add to Collection

Article Cell Biology

Integrin Structure, Activation, and Interactions

Iain D. Campbell et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)

Add to Collection

Review Biochemistry & Molecular Biology

The ADAM metalloproteinases

Dylan R. Edwards et al.

MOLECULAR ASPECTS OF MEDICINE (2008)

Add to Collection

Article Multidisciplinary Sciences

Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission

Yuko Fukata et al.

SCIENCE (2006)

Add to Collection

Article Cell Biology

Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members

Nathan J. Godde et al.

JOURNAL OF CELL SCIENCE (2006)

Add to Collection

Article Clinical Neurology

ADAM22, expressed in normal brain but not in high-grade gliomas, inhibits cellular proliferation via the disintegrin domain

GM D'Abaco et al.

NEUROSURGERY (2006)

Add to Collection

Article Biochemistry & Molecular Biology

ADAM22 plays an important role in cell adhesion and spreading with the assistance of 14-3-3

PC Zhu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)

Add to Collection

Article Neurosciences

Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice

K Sagane et al.

BMC NEUROSCIENCE (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.